CAR T-Cell Therapy in ALL: Formidible Challenges Remain

At the NCCN Annual Conference, Dr. Bijal Shah of Tampa ’s Moffitt Cancer Center highlighted ongoing challenges in administration of CAR T-cell therapy.

Source: CancerNetwork - April 4, 2018 Category: Cancer & Oncology Authors: Roxanne Nelson Tags: Acute Lymphoblastic Leukemia Conferences/NCCN News Source Type: news